Trials / Conditions / Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma
Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma
3 registered clinical trials studyying Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell NCT03422536 | University of Arizona | Phase 2 |
| Completed | Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who D NCT01256385 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer NCT00458978 | National Cancer Institute (NCI) | Phase 2 |